Systematic Financial Management Lp
Source: SEC Form 13F · as of Mar 2026Systematic Financial Management Lp holds 17 biotech & pharma companies tracked by BioSniper, totaling $217.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$217.1M
| Company | Shares | Value |
|---|---|---|
| JAZZJazz Pharmaceuticals plc | 407,114 | $77.0M |
| INVAInnoviva, Inc. | 2,024,082 | $47.2M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 376,079 | $19.4M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 747,515 | $18.5M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 255,354 | $14.4M |
| PRGOPERRIGO Co plc | 1,262,270 | $13.6M |
| AMPHAmphastar Pharmaceuticals, Inc. | 452,898 | $8.9M |
| MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. | 1,484,539 | $4.2M |
| QDELQuidelOrtho Corp | 225,853 | $3.7M |
| BIIBBIOGEN INC. | 16,220 | $3.0M |
| GEHCGE HealthCare Technologies Inc. | 34,355 | $2.4M |
| ABBVAbbVie Inc. | 9,300 | $2.0M |
| JNJJOHNSON & JOHNSON | 4,507 | $1.1M |
| MRKMerck & Co., Inc. | 7,300 | $878K |
| ELVElevance Health Inc. | 1,690 | $495K |
| ABTABBOTT LABORATORIES | 3,400 | $349K |
| OGNOrganon & Co. | 730 | $4K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.